Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Expert Review of Respiratory Medicine|May 19, 2010
Extrafine beclomethasone dipropionate/formoterol hydrofluoroalkane-propelled inhaler in asthmaPierluigi Paggiaro, Gabriele Nicolini, Alberto Papi
Respiration; International Review of Thoracic Diseases|July 12, 2022
Small Airways: Not Just Air Ducts - Pathophysiological Aspects and Clinical ImplicationsAnnalisa Frizzelli, Gabriele Nicolini, Alfredo Chetta
Pulmonary Pharmacology & Therapeutics|December 8, 2009
Inhaled corticosteroid therapy with nebulized beclometasone dipropionateGabriele Nicolini, Giovanni Cremonesi, Andrea S Melani
Expert Opinion on Drug Discovery|June 1, 2012
Ambroxol: a multifaceted molecule with additional therapeutic potentials in respiratory disorders of childhoodDavide Paleari, Giovanni A Rossi, Gabriele Nicolini, et al.
Expert Opinion on Pharmacotherapy|January 29, 2008
Inhaled beclometasone dipropionate/formoterol extra-fine fixed combination in the treatment of asthma: evidence and future perspectivesLeonardo Michele Fabbri, Gabriele Nicolini, Dario Olivieri, et al.
International Journal of General Medicine|October 11, 2012
Efficacy and safety of delapril/indapamide compared to different ACE-inhibitor/hydrochlorothiazide combinations: a meta-analysisMaria Circelli, Gabriele Nicolini, Colin G Egan, et al.
Therapeutics and Clinical Risk Management|February 12, 2009
Beclomethasone/formoterol fixed combination for the management of asthma: patient considerationsGabriele Nicolini, Nicola Scichilone, Andrea Bizzi, et al.
Allergy and Asthma Proceedings|April 25, 2012
Do inhaled corticosteroid/long-acting beta2-agonist fixed combinations provide superior clinical benefits compared with separate inhalers? A literature reappraisalPeter J Barnes, Gabriele Nicolini, Andrea Bizzi, et al.
Allergy and Asthma Proceedings|October 9, 2010
Both bronchial and alveolar exhaled nitric oxide are reduced with extrafine beclomethasone dipropionate in asthmaGabriele Nicolini, Alfredo Chetta, Anna Simonazzi, et al.
Respiratory Medicine|August 7, 2013
Stepping down from high dose fluticasone/salmeterol to extrafine BDP/F in asthma is cost-effectivePierluigi Paggiaro, Shishir Patel, Gabriele Nicolini, et al.
Pageof 4